コロンビア特別区における肺がんの臨床試験
コロンビア特別区内の拠点で、肺がんに関する27件の研究が参加者を募集しています。
コロンビア特別区内の都市
公式研究テキスト（英語）
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- George Washington University Medical Center, Washington D.C.
被験者募集中第3相
70歳以上 · 全性別 · 2026/10/05更新 · NCT06096844Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT04267848Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- George Washington University Medical Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT04181060Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Georgetown University, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07154290This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Washington DC Veterans Affairs Medical Center, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06712316Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- MedStar Georgetown University Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06287775Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Washington D.C.
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/30更新 · NCT06162221Gilteritinib for the Treatment of ALK NSCLC
- Georgetown University, Washington D.C.
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/26更新 · NCT06225427Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Georgetown University Medical Center, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/14更新 · NCT06922591Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
被験者募集中第2相
18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/23更新 · NCT02333604Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Sibley Memorial Hospital, Washington D.C.
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
- The George Washington University Hospital, Washington D.C.
被験者募集中第3相
18歳〜90歳 · 全性別 · 2026/04/09更新 · NCT06810375Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/16更新 · NCT04499053Erector Spinae Block for Thoracic Surgery
- The George Washington University, Washington D.C.
被験者募集中第4相
18歳〜90歳 · 全性別 · 2026/02/25更新 · NCT05521789LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- MedStar Georgetown University Hospital, Washington D.C.
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The George Washington University Cancer Center (site 212), Washington D.C.
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- MedStar Health, Washington D.C.
被験者募集中健康なボランティア歓迎
50歳〜80歳 · 全性別 · 2024/12/27更新 · NCT04675476ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。